🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

UPDATE 2-Travel stocks soar as encouraging vaccine study lifts Europe

Published 07/15/2020, 04:41 PM
Updated 07/16/2020, 12:40 AM
© Reuters.
MOWI
-
SEBa
-
SHBa
-
TEL2b
-
BRBY
-
ASOS
-
ASML
-
ATL
-
SALM
-
STOXX
-
SXNP
-
SXPP
-
SXTP
-
MRNA
-

(For a live blog on European stocks, type LIVE/ in an Eikon
news window)
* Euro zone blue-chips hit highest since March 5
* Italy's Atlantia soars as end of concession dispute nears
* Sweden's SEB slips as loan loss provision surges
* All eyes on ECB meeting, EU summit later this week

(Updates to market close)
By Sruthi Shankar
July 15 (Reuters) - European stocks closed at over a
five-week high on Wednesday, with travel stocks surfing a wave
of optimism following reports of progress in developing a
COVID-19 vaccine.
Hard-hit airline stocks like British Airways-owner IAG
ICAG.L , Ryanair RYA.I and Lufthansa LHAG.DE rose between
9.7% and 10.7%, while cruise operator Carnival Plc CCL.L
jumped 11.4%.
The travel & leisure index .SXTP surged 6.1% to lead
sectoral gains, but still remains the worst performer in Europe
this year with a 33% plunge as the coronavirus pandemic brought
global travel to a halt.
The pan-European STOXX 600 .STOXX rose 1.8%, closing just
short of levels last seen in early March, while euro zone
blue-chips .STOXX50E jumped 1.7% to hit their highest level
since March 5.
Investors were encouraged by an early-stage study on U.S.
biotech firm Moderna Inc's MRNA.O experimental vaccine for
COVID-19 that provoked immune responses. Meanwhile, AstraZeneca AZN.L jumped 5.2% after a report
said positive news on the University of Oxford's potential
COVID-19 vaccine that has been licensed to the drugmaker could
be announced as soon as Thursday. "Our central scenario is that a vaccine would be broadly
available from the second quarter of next year, or the fourth
quarter of this year in our upside scenario," Mark Haefele,
chief investment officer of UBS Global Wealth Management, told
clients.
"Various potential treatment options are also in the
pipeline, raising hopes that societies can cope with the
pandemic without full shutdowns."
Expectations were also high among investors heading into an
EU summit later this week that leaders will agree on a recovery
fund of 750 billion euros for pandemic-hammered economies.

The European Central Bank concludes its policy meeting on
Thursday although no major announcements are expected.
Among individual movers, Swedish telecom operator Tele2 AB
TEL2b.ST gained 2.9% as it reaffirmed its 2020 earnings
outlook and plans for an extra shareholder payout. The world's largest fish farmer Mowi ASA MOWI.OL jumped
6.8% as harvest volumes beat its own forecast. Shares in peer
Salmar SALM.OL rose 2.2%. The top gainer on the STOXX 600 was Atlantia SpA ATL.MI ,
which shot up 26.7% after the Italian infrastructure group and
its unit Autostrade made the government new offers to settle
their long-running dispute. Semiconductor equipment maker ASML Holding NV ASML.AS
declined 3.7% as it reported quarterly profit below estimates,
but forecast overall growth for 2020. Swedish bank SEB AB SEBa.ST fell 1.6% after reporting a
smaller-than-expected fall in net quarterly profit, but credit
loss provisions surged. Handelsbanken AB SHBa.ST also dropped
2.6%.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.